JP2023535815A5 - - Google Patents

Info

Publication number
JP2023535815A5
JP2023535815A5 JP2023506150A JP2023506150A JP2023535815A5 JP 2023535815 A5 JP2023535815 A5 JP 2023535815A5 JP 2023506150 A JP2023506150 A JP 2023506150A JP 2023506150 A JP2023506150 A JP 2023506150A JP 2023535815 A5 JP2023535815 A5 JP 2023535815A5
Authority
JP
Japan
Application number
JP2023506150A
Other languages
Japanese (ja)
Other versions
JPWO2022022559A5 (https=
JP2023535815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/108875 external-priority patent/WO2022022559A1/en
Publication of JP2023535815A publication Critical patent/JP2023535815A/ja
Publication of JP2023535815A5 publication Critical patent/JP2023535815A5/ja
Publication of JPWO2022022559A5 publication Critical patent/JPWO2022022559A5/ja
Pending legal-status Critical Current

Links

JP2023506150A 2020-07-29 2021-07-28 抗血小板薬およびその使用 Pending JP2023535815A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/105513 2020-07-29
CN2020105513 2020-07-29
PCT/CN2021/108875 WO2022022559A1 (en) 2020-07-29 2021-07-28 Antiplatelet drugs and uses thereof

Publications (3)

Publication Number Publication Date
JP2023535815A JP2023535815A (ja) 2023-08-21
JP2023535815A5 true JP2023535815A5 (https=) 2024-08-13
JPWO2022022559A5 JPWO2022022559A5 (https=) 2024-08-13

Family

ID=80037185

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023506150A Pending JP2023535815A (ja) 2020-07-29 2021-07-28 抗血小板薬およびその使用

Country Status (14)

Country Link
US (2) US12410132B2 (https=)
EP (2) EP4188935A4 (https=)
JP (1) JP2023535815A (https=)
KR (2) KR102906376B1 (https=)
CN (4) CN119033782B (https=)
AR (1) AR123078A1 (https=)
AU (1) AU2021317436A1 (https=)
BR (1) BR112023001595A2 (https=)
CA (1) CA3186645A1 (https=)
ES (1) ES3046366T3 (https=)
IL (1) IL299979A (https=)
MX (1) MX2023001232A (https=)
TW (1) TW202214609A (https=)
WO (1) WO2022022559A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202339745A (zh) * 2022-01-28 2023-10-16 大陸商上海柯君醫藥科技有限公司 抗血小板藥物的藥物組合物及其用途
CN116813532A (zh) * 2023-06-29 2023-09-29 上海柯君医药科技有限公司 一种哌啶化合物的制备方法
WO2025108307A1 (zh) * 2023-11-24 2025-05-30 上海柯君医药科技有限公司 一种含哌啶环化合物的苯磺酸盐、其制备方法及应用
WO2025108300A1 (zh) * 2023-11-24 2025-05-30 上海柯君医药科技有限公司 一种含哌啶环化合物的苯磺酸盐的晶型、其制备方法及应用
CN119019320B (zh) * 2024-10-29 2025-03-11 上海柯君医药科技有限公司 一种具有抗血小板活性的哌啶类化合物的制备方法
CN119176829B (zh) * 2024-11-26 2025-04-15 上海柯君医药科技有限公司 一种哌啶环化合物的制备方法
CN119192061B (zh) * 2024-11-28 2025-05-13 上海柯君医药科技有限公司 一种含哌啶环的化合物的纯化方法
CN119371453A (zh) * 2024-12-30 2025-01-28 上海柯君医药科技有限公司 一种抗血小板药物中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334389A (en) 1996-08-28 2001-05-25 Ube Industries Cyclic amine derivatives
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
CN104379589A (zh) * 2012-05-07 2015-02-25 塞利克斯比奥私人有限公司 抗血小板药剂的前药
KR20150038369A (ko) * 2012-08-03 2015-04-08 브리스톨-마이어스 스큅 컴퍼니 인자 XIa 억제제로서의 디히드로피리돈 P1
CN103626694A (zh) * 2012-08-29 2014-03-12 中国药科大学 不饱和环胺衍生物、其制备方法及其医药用途
NO2721243T3 (https=) * 2014-10-01 2018-10-20
CN106554303A (zh) * 2015-09-25 2017-04-05 陕西合成药业股份有限公司 噻吩并吡啶类衍生物及其制备方法和用途
CN106554368A (zh) * 2015-09-25 2017-04-05 陕西合成药业股份有限公司 噻吩并吡啶类衍生物及其制备方法和用途
CN119019320B (zh) * 2024-10-29 2025-03-11 上海柯君医药科技有限公司 一种具有抗血小板活性的哌啶类化合物的制备方法
CN119192061B (zh) * 2024-11-28 2025-05-13 上海柯君医药科技有限公司 一种含哌啶环的化合物的纯化方法

Similar Documents

Publication Publication Date Title
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2023535815A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112023011738A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016200A2 (https=)
BR102021016176A2 (https=)
BR102021015566A2 (https=)
BR102021015450A8 (https=)
BR102021015247A2 (https=)